Olfr101 inhibitors are a diverse group of chemicals that indirectly influence the activity of the Olfactory Receptor 101. These inhibitors primarily target signaling pathways and cellular processes that are upstream or downstream of the receptor's function. Olfr101, like other olfactory receptors, is part of the G protein-coupled receptor (GPCR) family, which is why most of these inhibitors focus on modulating the GPCR signaling pathway. This pathway is intricate, involving a series of enzymatic reactions and protein interactions that ultimately lead to olfactory signal transduction. The chemicals listed target various components of this signaling cascade, such as adenylate cyclase, protein kinases, phospholipases, and MAP kinases. The inhibition methods employed by these chemicals are diverse. For example, Forskolin increases cAMP levels by activating adenylate cyclase, indirectly influencing the receptor's signaling mechanism.
On the other hand, compounds like U73122 and LY294002 act by inhibiting key enzymes like phospholipase C and PI3K, respectively, thus modulating the downstream effects of receptor activation. Staurosporine and Genistein exhibit broader activity, targeting multiple kinases and potentially affecting several pathways simultaneously. This broad approach is necessary due to the complex nature of GPCR signaling and the lack of direct inhibitors specific to Olfr101. The study of these inhibitors is crucial in understanding the molecular dynamics of olfactory receptors. By analyzing how these chemicals influence Olfr101, researchers can gain insights into the receptor's role in olfactory signaling and potentially uncover new aspects of olfactory perception. Additionally, this knowledge aids in the development of more targeted and efficient inhibitors, which could have implications in various research contexts. It's important to note that while these inhibitors provide valuable tools for studying Olfr101, their effects on other proteins and pathways should be considered, as they are not exclusive to this specific receptor.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A inhibits protein transport and interferes with the G protein-coupled receptor (GPCR) signaling pathway, which may indirectly affect Olfr101. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, modulating cAMP levels, which are crucial in olfactory signaling, potentially influencing Olfr101. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
KT5720 is a potent inhibitor of protein kinase A (PKA), a key player in the GPCR pathway, thus indirectly affecting Olfr101 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, affecting downstream signaling pathways involved in GPCR function, which may influence Olfr101. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine broadly inhibits protein kinases, affecting multiple pathways including those related to GPCR signaling, possibly impacting Olfr101. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 specifically inhibits MEK, which is part of the MAPK/ERK pathway linked to GPCR signaling, potentially affecting Olfr101. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which may indirectly affect the signaling pathways associated with Olfr101. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, influencing pathways that can indirectly impact Olfr101 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K, which can indirectly affect GPCR-related pathways, potentially influencing Olfr101. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
GF109203X is a protein kinase C inhibitor, which can modify signaling pathways related to Olfr101 function. | ||||||